Endovascular embolization of renal cell carcinoma in a patient with solitary kidney by Kuklik, Ewa et al.
Endovascular Embolization of Renal Cell Carcinoma in a 
Patient with Solitary Kidney
Ewa KuklikABCDEFG, Łukasz ŚwiatłowskiABCDEFG, Michał SojkaABDFG, 
Małgorzata Szczerbo-TrojanowskaABCDEFG
Department of Radiology and Interventional Neuroradiology, Independent Public Hospital No. 4 (SPSK 4), Lublin, Poland
Author’s address: Ewa Kuklik, Department of Radiology and Interventional Neuroradiology, Independent Public Hospital 
No. 4 (SPSK 4), Jaczewskiego 8 Str., 20-001 Lublin, Poland, e-mail: ekuklik5@wp.pl
 Summary
 Background: Kidney tumors account for about 3% of tumors in adults. The primary therapy of renal cancer 
is the surgical removal. Traditionally, and also modern procedures are performed to remove the 
kidneys, especially when the tumor involves the entire kidney. In the cases of unresectable tumors 
embolization is used as a palliative procedure. 
 Case Report: The aim of this study is to present the case of endovascular treatment of renal cell carcinoma 
in patient with solitary kidney. 77-years old patient had an ultrasound examination because of 
the pain in left lumbar region. MRI confirmed the presence of tumor size 29×45 mm in the left 
kidney. The right kidney had been removed eight years earlier because of clear cell carcinoma. 
Histopathological diagnosis was renal clear cell carinoma. The patient did not consent to surgical 
treatment. Tumor embolization was proceeded as a minimally invasive procedure. Pathological 
tumor vessels were closed using particles filling the entire vascular tumor. Next, the blood 
vessels supplying the tumor were closed using a mixture of lipiodolu and glubranu. Control 
angiographiy of the left renal artery confirmed the effective closure of all vascular pathology. In 
a recent ultrasound examination which was done 15 months after surgery no evidence of vascular 
pathology was found. 
 Conclusions: Embolization of kidney cancer in particular cases may be an alternative way of treatment and 
give a good result in the form of stopping the growth of the tumor with simultaneous retaining the 
remaining parenchyma and renal function.
 MeSH Keywords:  Carcinoma, Renal Cell • Embolization, Therapeutic • Neoplastic Cells, Circulating





Kidney tumors account for about 3% of tumors in adults. We 
can distinguish several types of malignant kidney tumors of 
which renal cell carcinoma is the most common. It is respon-
sible for about 75% of all malignant kidney tumors and 80% 
of histopathological diagnoses of renal cancer are renal clear 
cell carcinomas [1]. Kidney tumors are slightly more common 
in men than in women. The disease usually develops between 
50 and 70 years of age. The primary therapy of renal cancer 
is surgical removal, especially when the tumor involves an 
entire kidney. When a kidney tumor is small, enucleation sur-
gery is the standard treatment, which means selective exci-
sion of the tumor mass or partial nephrectomy [2].
In unresectable tumors, embolization is used as a palliative 
procedure. The treatment consists of catheterization of the 
renal artery branch that is supplying the tumor in order to 
achieve selective closure of the vessel. Embolization allows 
to reduce tumor growth, alleviate pain and inhibit possible 
bleeding from the tumor.
Case Report
A 77-year-old patient had an ultrasound examina-
tion because of the pain in the left lumbar region, which 
showed a tumor-like change in the left kidney. MRI con-
firmed the presence of the tumor (size 29×45 mm) in the 
lower pole of the left kidney. The right kidney had been 
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C A S E  R E P O R T
removed eight years earlier because of clear cell carcinoma. 
The image of the left kidney tumor suggested a metaplastic 
change as an initial diagnosis. Targeted biopsy confirmed 
the presence of tumor that was diagnosed as renal clear cell 
carcinoma on a histopathological examination. The patient 
did not consent to surgical treatment. Tumor embolization 
was performed as a minimally invasive procedure. Firstly, 
a DSA examination was performed by puncturing the right 
femoral artery under local anesthesia using the Seldinger 
method. With a Levin catheter, we catheterized the left 
renal artery. On angiography, we visualized the tumor 
mass in the lower pole of the kidney, which measured 
approximately 45×25 mm (Figures 1, 2). The tumor was 
characterized by a rich vasculature, typical for clear cell 
carcinoma. Then, with a type Progreate microcatheter, the 
small vessels supplying the tumor were selectively cath-
eterized (Figure 3). Pathological tumor vessels were closed 
with Embozene 250-um particles filling the entire vascular 
tumor. Subsequently, the blood vessels supplying the tumor 
were closed using a mixture of lipiodol and glubran (in a 
proportion of 40–60%). A control angiography of the left 
renal artery confirmed an effective closure of all vascular 
pathologies (Figure 4).
The remaining part of the vasculature of the kidney was 
normal. The course of the procedure and surgery was with-
out complications. The patient was discharged home on the 
2nd day of hospitalization with a recommendation to under-
go an ultrasound examination in a month and then every 6 
months.
The ultrasound examination performed one month 
after the procedure showed normal renal vasculature. 
Figure 1.  Angiography of the left renal artery before the procedure 
showing tumor mass in the lower pole of the kidney, 
measuring approximately 45×25 mm. Arterial phase.
Figure 3. Selective angiography of the tumor mass.
Figure 4.  Control angiography of the left renal artery after the 
procedure showed effective closure of the vascular 
pathology.
Figure 2.  Angiography of the left renal artery before the procedure 
showing tumor mass in the lower pole of the kidney, 
measuring approximately 45×25mm. Arterial phase, tissue 
phase.
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Pathological vascularization in the lower pole of left kidney 
was not found.
In a recent ultrasound examination, which was done 
15 months after the procedure, no evidence of vascular 
pathology was found. The condition of the kidney did not 
change in comparison to the study carried out one year 
before (one month after embolization).
Discussion
In the early stages, renal cancer is usually asymptomat-
ic. The typical triad of hematuria, pain and presence of a 
palpable tumor is seen in about 5–15% of cases. In most 
patients, renal cancer is discovered accidentally while per-
forming imaging of the abdomen [3].
Renal cell carcinoma metastases spread by both the circula-
tory and lymphatic routes. Most metastases are seen in the 
lungs (50–60%), bones (30–40%), liver (30–40%), lymph nodes 
(36%) and brain (5%) [4]. Bilateral kidney tumors are extreme-
ly rare and are represent in only about 1–3% of cases [5].
Almgard was the first to popularize embolization of renal 
tumors in the 1970s. Indications for renal artery emboli-
zation for the treatment of renal tumors include support-
ing treatment before nephrectomy, palliative therapy and 
treatment of angiomyolipomas [2].
Nurmi et al. described a group of 25 patients with renal 
cancer who were treated with embolization of the renal 
artery. The aim of the procedure was to stop bleeding from 
the urinary tract and to alleviate pain. An effective inhibi-
tion of bleeding was achieved in 11 of the 14 patients with 
bleeding, and pain disappeared in 50% of cases. There was 
no prolongation of survival. All patients who underwent 
follow-up died of renal cancer within 38 months. In one 
patient, ethanol embolization was complicated by necrosis 
of the colon [6].
In the scientific literature, there are reports on the immu-
nomodulatory effects of radioembolization (RAE). Zielinski 
et al. describe the use of this procedure in 234 patients 
with kidney cancer. One-hundred-eighteen subjects under-
went preoperative embolization and then nephrectomy, and 
the remaining 116 subjects underwent only nephrectomy. 
The overall 5-year and 10-year survival rates were as fol-
lows: 62% and 47% in the group treated with preoperative 
embolization, and only 35% and 23% in the group treated 
surgically, respectively [7].
In recent years, there have been more and more reports 
on the treatment of renal tumors by radiofrequency abla-
tion (RFA). It results in the destruction of the tumor with 
radiofrequency waves under the guidance of MRI, CT and 
ultrasound. Initially, radiofrequency ablation was used 
in the treatment of primary and metastatic tumors of the 
liver. The first use of radiofrequency ablation for the treat-
ment of renal tumors was described in 1997 [8].
Since then, many studies have been published that have 
demonstrated the efficacy of ablation for the treatment of 
kidney tumors with a simultaneous maintenance of kid-
ney function. Best et al. reported of the use of radiofre-
quency ablation as a primary treatment for renal tumors. 
The treatment was performed in 159 patients with renal 
tumors, including 138 patients with a histopathologi-
cal diagnosis of clear cell carcinoma. The results showed 
a longer survival time in patients with tumors that had a 
diameter smaller than 3 cm, and 3-year and 5-year survival 
times were 96% and 95%, respectively. In tumors with a 
diameter larger than 3 cm, 3-year and 5-year average sur-
vival times were 79% and 79%, respectively [9]. Soo Dong 
Kim et al. described percutaneous radiofrequency ablation 
for the treatment of renal tumors in 36 patients. During 
49 months of follow-up, local recurrence occurred in 3 
patients, which was most likely due to technical imperfec-
tions of the intervention with incomplete ablation of the 
tumor. Patients with a known cancer recurrence under-
went re-ablation of the tumor with satisfactory results [10]. 
The efficacy of radiofrequency ablation in the long-term 
observation was also presented. The results of the publi-
cation indicate that the procedure is effective, also in the 
long-term observation. Good treatment outcomes depend 
on appropriate qualification of patients, and the main indi-
cator of the effectiveness of treatment is tumor size. The 
best results are obtained with small tumors, up to 3 cm in 
diameter [9]. In our case, the clear cell tumor of the left 
kidney could be treated as a metastatic change or a new 
primary lesion. Eight years before, when the right kidney 
was removed because of cancer, the image of the left kid-
ney was normal. Because of lack of patient consent for 
surgery and the inability to perform thermoablation, we 
decided to treat the kidney tumor by superselective embo-
lization of the pathological vessels of the tumor. So far, we 
have not found any cases of embolization of solitary kidney 
tumors as the initial and only treatment. This procedure 
is not a standard treatment. However, observation of this 
patient indicates that the embolization of kidney cancer in 
certain cases may be an alternative way of treatment and 
could give good results by inhibiting tumor growth with 
a simultaneous maintenance of function of the remaining 
renal parenchyma.
Conclusions
Embolization of kidney cancer in certain cases may be an 
alternative way of treatment and could give good results by 
inhibiting tumor growth with a simultaneous maintenance 
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